EdgarLookup

Silo Pharma, Inc. — All Filings

349 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 3/A 4 4/A 40-17G 424B3 424B4 424B5 8-A12B 8-A12G 8-K 8-K/A 8-K12B ARS CERT CORRESP D D/A DEF 14A DEF 14C DEFA14A DEFR14A DRS EFFECT N-54A N-54C NT 10-K NT 10-Q POS AM PRE 14A PRE 14C S-1 S-1/A S-3 S-3/A SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
10-K ANNUAL REPORT 0001213900-26-035576 Mar 27, 2026 Dec 31, 2025
8-K CURRENT REPORT 0001213900-26-019384 Feb 23, 2026 Feb 20, 2026
SCHEDULE 13G/A 0001193125-26-053479 Feb 17, 2026
SCHEDULE 13G/A 0001213900-26-016528 Feb 13, 2026
SCHEDULE 13G/A 0001213900-26-016071 Feb 13, 2026
8-K CURRENT REPORT 0001213900-25-125838 Dec 29, 2025 Dec 24, 2025
4 0001213900-25-122429 Dec 16, 2025 Dec 15, 2025
EFFECT 9999999995-25-003402 Nov 26, 2025
424B3 PROSPECTUS 0001213900-25-115503 Nov 26, 2025
4 0001213900-25-113743 Nov 21, 2025 Nov 20, 2025
4 0001213900-25-113104 Nov 20, 2025 Nov 18, 2025
SCHEDULE 13G 0001193125-25-282676 Nov 14, 2025
10-Q QUARTERLY REPORT 0001213900-25-110006 Nov 13, 2025 Sep 30, 2025
SCHEDULE 13G/A 0001213900-25-107728 Nov 7, 2025
S-1 REGISTRATION STATEMENT 0001213900-25-103188 Oct 29, 2025
8-K CURRENT REPORT 0001213900-25-102222 Oct 24, 2025
SCHEDULE 13G 0001213900-25-096008 Oct 3, 2025
8-K CURRENT REPORT 0001213900-25-094711 Oct 1, 2025 Sep 29, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-094384 Oct 1, 2025
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-085128 Sep 5, 2025
ARS ARS 0001213900-25-085125 Sep 5, 2025 Dec 31, 2024
DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-085119 Sep 5, 2025 Oct 24, 2025
PRE 14A PRELIMINARY PROXY STATEMENT 0002077096-25-000053 Aug 25, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-077936 Aug 18, 2025
10-Q QUARTERLY REPORT 0001213900-25-075693 Aug 13, 2025 Jun 30, 2025
SCHEDULE 13G/A 0001213900-25-075089 Aug 12, 2025
8-K CURRENT REPORT 0001213900-25-072062 Aug 5, 2025 Aug 4, 2025
8-K CURRENT REPORT 0001213900-25-068740 Jul 29, 2025
8-K CURRENT REPORT 0001213900-25-062805 Jul 10, 2025 Jul 8, 2025
8-K CURRENT REPORT 0001213900-25-061531 Jul 3, 2025 Jun 27, 2025
4 0001213900-25-048304 May 28, 2025 May 27, 2025
4 0001213900-25-047915 May 27, 2025 May 23, 2025
4 0001213900-25-047914 May 27, 2025 May 23, 2025
4 0001213900-25-047913 May 27, 2025 May 23, 2025
4 0001213900-25-047912 May 27, 2025 May 23, 2025
4 0001213900-25-047910 May 27, 2025 May 23, 2025
SCHEDULE 13G 0001213900-25-046498 May 21, 2025
8-K CURRENT REPORT 0001213900-25-044913 May 16, 2025 May 15, 2025
424B4 PROSPECTUS 0001213900-25-044625 May 16, 2025
EFFECT 9999999995-25-001623 May 15, 2025
CORRESP 0001213900-25-041880 May 12, 2025
S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-25-041563 May 9, 2025
10-Q QUARTERLY REPORT 0001213900-25-041519 May 9, 2025 Mar 31, 2025
CORRESP 0001213900-25-037247 Apr 30, 2025
S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-036374 Apr 29, 2025
CORRESP 0001213900-25-036149 Apr 28, 2025
S-1 REGISTRATION STATEMENT 0001213900-25-035652 Apr 25, 2025
UPLOAD 0000000000-25-004102 Apr 17, 2025
DRS 0001213900-25-030817 Apr 11, 2025
424B3 PROSPECTUS 0001213900-25-029067 Apr 4, 2025